Group Post |
How to Get Vaccinated, Tested and Treated for Monkeypox |
FNUOvviyaa |
Group Post |
White House scrambles to play catch-up on monkeypox response |
FNUOvviyaa |
Group Post |
Long COVID Neurologic Symptoms Vary Based on Severity of Initial Infection |
FNUOvviyaa |
Group Post |
Cheers and fears as US ends mask mandates for travel |
FNUOvviyaa |
Group Post |
Pfizer-BioNTech vaccine effective for children under 5: FDA staff |
FNUOvviyaa |
Group Post |
Menstrual changes after Covid vaccines may be far more common than previously known |
FNUOvviyaa |
Group Post |
Lessons from COVID require tough questions |
FNUOvviyaa |
Group Post |
Africa’s alone in monkeypox deaths but has no vaccine doses |
FNUOvviyaa |
Group Post |
Coronavirus map: Confirmed Covid cases, per country |
FNUOvviyaa |
Group Post |
This invisible Covid-19 mitigation measure is finally getting the attention it deserves |
FNUOvviyaa |
Group Post |
Moderna says updated COVID shot boosts omicron protection |
FNUOvviyaa |
Group Post |
Covid: Sore throat now top symptom that could be the virus |
FNUOvviyaa |
Group Post |
WHO, WIPO, WTO call for innovation and cooperation to support timely access to pandemic products |
FNUOvviyaa |
Group Post |
Monkeypox: How it spreads, who’s at risk - here’s what you need to know |
FNUOvviyaa |
Group Post |
Change in monkeypox vaccine injection method could mean more doses but may not be easy, experts say |
FNUOvviyaa |
Group Post |
FDA advisers vote in favor of authorizing Moderna Covid-19 vaccine for ages 6-17 |
FNUOvviyaa |
Group Post |
Gawande warns USAID COVID response quickly running out of money |
FNUOvviyaa |
Group Post |
Are U.S. Healthcare Workers Better Off Unionized? |
FNUOvviyaa |
Group Post |
San Francisco, New York Declare Monkeypox An Emergency |
FNUOvviyaa |
Group Post |
FDA offers radio silence on question of spring Covid boosters, as other countries push ahead |
FNUOvviyaa |
Group Post |
The extraordinary success of Covid-19 vaccines, in two charts |
FNUOvviyaa |
Group Post |
BA.5 is causing more Covid-19 reinfections, data suggests, but they don't appear to be more frequent |
FNUOvviyaa |
Group Post |
COVID variant XBB.1.5 now accounts for 40 percent of cases in the US: CDC |
FNUOvviyaa |
Group Post |
Axcella long COVID treatment helps some patients in small trial |
FNUOvviyaa |
Group Post |
Court blocks Covid vaccine mandate for U.S. government workers |
FNUOvviyaa |
Recent Comments